Parkside exibiu Aplicativo móvel para analisar a fertilidade das mulheres em DMEA 2023.
A mobile app designed to analyze the fertility of women has been created by Austrian company Parkside and showcased at the DMEA 2023 event. The company produces bespoke software, including mobile applications and platforms, with around 50% of its clients in the US and the rest in German-speaking countries. Other medical products developed by Parkside include a mobile app for cancer patients to track their medication and communicate with their doctors. The company offers a flexible approach to product creation, tailoring their services to meet each client’s specific needs.Generated by OpenAI
